| Literature DB >> 11928799 |
Michael I Dangelica1, Margo C Shoup, Aviram Nissan.
Abstract
The treatment of advanced colorectal cancer has long been a dilemma for clinicians. After many years of therapy limited to 5-fluorouracil (5-FU)-based chemotherapy, a number of new discoveries have significantly advanced this field in the last decade. The advent of irinotecan has given us hope for a second line chemotherapeutic agent and a possible new combination for first line chemotherapy.Entities:
Mesh：
Substances：
Year: 2002 PMID： 11928799 DOI： 10.1016/s1055-3207(03)00080-2
Source DB: PubMed Journal: Surg Oncol Clin N Am ISSN： 1055-3207 Impact factor: 3.495